Philippines Pharmaceuticals & Healthcare Views

FDA Recalls B. Braun’s IV Solution

The Philippine Food and Drug Administration (FDA) has recalled 8.4% Sodium Bicarbonate Solution for intravenous (IV) infusion manufactured by German pharmaceutical company B. Braun Melsungen.

Read article ›
Asia Pacific Remains Highly Attractive

Geographic diversification may be a favourable strategy for multinational pharmaceutical companies, but it is vital that firms recognise both the rewards and the risks present in a market, whether...

Read article ›